Project Grant R41DK143882
Award Date 9/8/25
Completion Date 8/31/26
Dollars Obligated $325K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Marietta, GA 30062, USA
Similar Awards
- This $177,986 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to Vanderbilt University Medical Center supports a pilot, phase II, open-label clinical trial. The study aims to determine the impact of administering the adjuvant weight loss medication tirzepatide (TRZ) on weight, fat mass, and lean body mass in patients with a history of gastric bypass surgery. The 5-year project, beginning September 9, 2025 and ending July 31, 2030,...
- This federal Project Grant award of $828,771 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to study the neural mechanisms underlying the metabolic benefits of bariatric surgeries, such as vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB). The key objectives are to employ electrophysiological techniques to analyze changes in neuronal excitability and...
- This Project Grant award of $3,103,125 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the role of lipogenic pathways in intestinal remodeling after Roux-en-Y gastric bypass surgery. The central hypothesis is that alterations in intestinal epithelial lipid homeostasis, driven by LXR and PPARA signaling, are necessary for Roux limb...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $324,678 Project Grant to Lumina Medical LLC, located in California, to develop an innovative Motorized Girth Adjustable Dilator. This medical device is designed to improve patient adherence to static-passive stretching treatment for anorectal disorders such as anismus and anal stenosis, which collectively affect...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $226,192 to Endonavis LLC to develop a novel over-the-scope platform for controlling variceal bleeding. The project aims to mate Endonavis' single-use endoscope technology with a novel balloon design to enable endoscopic visualization and active monitoring during placement for improved...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $728,801 Project Grant to the Regents of the University of Michigan under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a 5-year project to test a novel weight navigation program aimed at overcoming barriers to obesity treatment in primary care settings. The project seeks to improve utilization of effective...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,192,362 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Averto Medical Inc., a medical device manufacturer in Fremont, California. The grant supports a safety and efficacy clinical trial of Averto's COLOSEAL ICD System, a minimally invasive medical device designed as an alternative to temporary ostomies for the surgical treatment of...
- This $942,000 federal project grant was awarded on September 16, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a feasibility project at Rush University Medical Center to develop a primary care-based weight management treatment program for individuals discontinuing anti-obesity medications (AOMs). The goal is to quickly identify patients who...
- This Project Grant award of $2,608,068.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is funding research to study the impact of bariatric surgery on skeletal health. The primary objectives are to investigate how changes in gastric secretory factors, such as ghrelin and somatostatin, contribute to bone loss following vertical sleeve gastrectomy (VSG) surgery. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...